Evaluation serology nasopharyngeal cultures diagnosis pertussis vaccine efficacy trial Nasopharyngeal cultures titer rises paired sera placebo-controlled pertussis vaccine efficacy trial IgG ELISA filamentous hemagglutinin FHA placebo recipients vaccine recipients culture-verified Bordetella pertussis infections whereas IgG ELISA pertussis toxin PT diagnostic sensitivity placebo group vaccine groups CHO cell sensitivity Children Bordetella parapertussis infections rises titers antibody FHA magnitude children pertussis infections Sensitive serologic criteria intraassay variations additional culture-negative cases significant titer rises paired sera IgG ELISA FHA PT IgA ELISA FHA reliable assays bacterial isolation rates vaccine recipients placebo recipients pertussis 